• Product NameEstropipate
• Brief DescriptionInhibitors
• Purification98.86%
• Biological ActivityEstropipate is a form of estrogen. It has several uses such as: Alleviate symptoms of menopause as hormone replacement therapy, treatment some types of infertility, treatment of some conditions leading to underdevelopment of female sexual characteristics,treatment of vaginal atrophy,treatment of some types of breast Y (particularly in men and postmenopausal women), treatment of prostate Y and prevention of osteoporosis.
• Target NameEstrogen/progestogen Receptor agonist
• CAS No. 7280-37-7
• Calculated MW 436.56
• Formulation C22H32N2O5S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1
  Pathways:Endocrinology/Hormones
  Receptor:ER
  Boling pt:
  Melting pt:
  Solubility:DMSO: 35mg/mL
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Brama M, et al. Mol Cell Endocrinol. 2007 Jan 29;264(1-2):102-8.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting